NanoVibronix Past Earnings Performance
Past criteria checks 0/6
NanoVibronix's earnings have been declining at an average annual rate of -4%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 27.1% per year.
Key information
-4.0%
Earnings growth rate
7.2%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 27.1% |
| Return on equity | -93.1% |
| Net Margin | -162.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Most Shareholders Will Probably Find That The Compensation For NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Is Reasonable
Dec 09
NanoVibronix receives extension to satisfy Nasdaq bid price requirement
Oct 19NanoVibronix rises 27% on approval of Uroshield for sale in UK by NHS internal supply chain contract
Sep 23Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely?
Jul 08Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely?
Mar 22Is NanoVibronix (NASDAQ:NAOV) In A Good Position To Deliver On Growth Plans?
Dec 01NanoVibronix: Portable Ultrasonic Therapeutic Devices
Sep 01NanoVibronix (NASDAQ:NAOV) Is In A Good Position To Deliver On Growth Plans
Aug 17NanoVibronix announces expansion of distribution pact for its ultrasound devices
Dec 11NanoVibronix secures $6M in equity capital
Dec 02NanoVibronix reports Q3 results
Nov 17Revenue & Expenses BreakdownBeta
How NanoVibronix makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2 | -4 | 4 | 0 |
| 30 Sep 23 | 1 | -5 | 4 | 0 |
| 30 Jun 23 | 1 | -5 | 4 | 0 |
| 31 Mar 23 | 1 | -5 | 5 | 0 |
| 31 Dec 22 | 1 | -5 | 5 | 0 |
| 30 Sep 22 | 2 | -6 | 5 | 0 |
| 30 Jun 22 | 2 | -12 | 5 | 0 |
| 31 Mar 22 | 2 | -10 | 4 | 0 |
| 31 Dec 21 | 2 | -14 | 5 | 0 |
| 30 Sep 21 | 1 | -13 | 5 | 0 |
| 30 Jun 21 | 1 | -7 | 5 | 0 |
| 31 Mar 21 | 1 | -8 | 5 | 0 |
| 31 Dec 20 | 1 | -4 | 5 | 0 |
| 30 Sep 20 | 1 | -5 | 4 | 0 |
| 30 Jun 20 | 1 | -4 | 4 | 0 |
| 31 Mar 20 | 1 | -4 | 4 | 0 |
| 31 Dec 19 | 1 | -6 | 5 | 1 |
| 30 Sep 19 | 0 | -6 | 5 | 1 |
| 30 Jun 19 | 0 | -6 | 5 | 1 |
| 31 Mar 19 | 0 | -6 | 5 | 1 |
| 31 Dec 18 | 0 | -4 | 4 | 1 |
| 30 Sep 18 | 0 | -5 | 4 | 1 |
| 30 Jun 18 | 0 | -5 | 3 | 1 |
| 31 Mar 18 | 0 | -6 | 3 | 1 |
| 31 Dec 17 | 0 | -6 | 3 | 1 |
| 30 Sep 17 | 0 | -5 | 2 | 1 |
| 30 Jun 17 | 0 | -4 | 2 | 1 |
| 31 Mar 17 | 0 | -3 | 2 | 1 |
| 31 Dec 16 | 0 | -3 | 2 | 1 |
| 30 Sep 16 | 0 | -2 | 2 | 1 |
| 30 Jun 16 | 0 | -3 | 1 | 0 |
| 31 Mar 16 | 0 | -3 | 1 | 0 |
| 31 Dec 15 | 0 | -3 | 1 | 0 |
| 30 Sep 15 | 0 | -3 | 1 | 0 |
| 30 Jun 15 | 0 | -3 | 1 | 0 |
| 31 Mar 15 | 0 | -3 | 1 | 0 |
| 31 Dec 14 | 0 | -3 | 1 | 0 |
| 30 Sep 14 | 0 | -2 | 1 | 0 |
| 30 Jun 14 | 0 | -2 | 0 | 0 |
| 31 Mar 14 | 0 | -2 | 0 | 0 |
| 31 Dec 13 | 0 | -2 | 1 | 1 |
| 30 Sep 13 | 0 | -2 | 1 | 1 |
| 30 Jun 13 | 0 | -2 | 1 | 1 |
Quality Earnings: NAOV is currently unprofitable.
Growing Profit Margin: NAOV is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NAOV is unprofitable, and losses have increased over the past 5 years at a rate of 4% per year.
Accelerating Growth: Unable to compare NAOV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NAOV is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.5%).
Return on Equity
High ROE: NAOV has a negative Return on Equity (-93.05%), as it is currently unprofitable.